Evidence map›Paper›PMID 32482868›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

MYC protein stability is negatively regulated by BRD4.

Ballachanda N Devaiah, Jie Mu, Ben Akman, Sheetal Uppal, Jocelyn D Weissman, Dan Cheng, Laura Baranello, Zuqin Nie, David Levens, Dinah S Singer

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. TSProm: Deciphering the Genomic Context of Tissue Specificity.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ballachanda N DevaiahExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892.
Jie MuExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892.ORCID 0000-0001-9885-3826
Ben AkmanExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892.
Sheetal UppalExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892.ORCID 0000-0002-2627-2536
Jocelyn D WeissmanExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892.
Dan ChengExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892.
Laura BaranelloLaboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD 20892.
Zuqin NieLaboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD 20892.
David LevensLaboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD 20892.
Dinah S SingerExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892; dinah.singer@nih.gov.
National Cancer Institute · US

Funding

Mechanisms of transcription factor integration at the c-myc promoterZIASC009144 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI LEVENS, DAVID L. · 2009 to 2025
$9.5M
c-Myc FunctionZIABC011465 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEVENS, DAVID L. · 2012 to 2025
$8.6M
Brd4 is an atypical kinase that regulates transcriptionZIABC011381 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, DINAH S. · 2011 to 2025
$5.4M
Interactions Between MYC and BRD4 Result in Their Reciprocal RegulationZIABC011882 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, DINAH S. · 2019 to 2022
$1.8M
6 · The paper itself

Abstract

The protooncogene MYC regulates a variety of cellular processes, including proliferation and metabolism. Maintaining MYC at homeostatic levels is critical to normal cell function; overexpression drives many cancers. MYC stability is regulated through phosphorylation: phosphorylation at Thr58 signals degradation while Ser62 phosphorylation leads to its stabilization and functional activation. The bromodomain protein 4 (BRD4) is a transcriptional and epigenetic regulator with intrinsic kinase and histone acetyltransferase (HAT) activities that activates transcription of key protooncogenes, including

Indexed as

AcetylationBromodomain Containing ProteinsCell Cycle ProteinsCell NucleusChromatinDipeptidesGene Expression RegulationHeLa CellsHeterocyclic Compounds, 3-RingHistonesHumansMitogen-Activated Protein Kinase 3PhosphorylationProtein BindingProtein StabilityProto-Oncogene Proteins c-mycBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsChromatinDipeptidesHeterocyclic Compounds, 3-RingHistonesMAPK3 protein, humanMitogen-Activated Protein Kinase 3MYC protein, humanMZ1 compoundProto-Oncogene Proteins c-mycTranscription FactorsBRD4 histone acetyltransferaseBRD4 kinaseERK1MYC phosphorylationMYC stability

Identifiers

PMID32482868
PMCPMC7306749
OpenAlexW3030510106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.